JP2014505655A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505655A5 JP2014505655A5 JP2013530433A JP2013530433A JP2014505655A5 JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5 JP 2013530433 A JP2013530433 A JP 2013530433A JP 2013530433 A JP2013530433 A JP 2013530433A JP 2014505655 A5 JP2014505655 A5 JP 2014505655A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- seq
- chimeric
- peptide according
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38743910P | 2010-09-28 | 2010-09-28 | |
| US61/387,439 | 2010-09-28 | ||
| PCT/US2011/053764 WO2012050921A2 (en) | 2010-09-28 | 2011-09-28 | Nd2 peptides and methods of treating neurological disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505655A JP2014505655A (ja) | 2014-03-06 |
| JP2014505655A5 true JP2014505655A5 (https=) | 2016-02-25 |
| JP6073230B2 JP6073230B2 (ja) | 2017-02-01 |
Family
ID=45938878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013530433A Expired - Fee Related JP6073230B2 (ja) | 2010-09-28 | 2011-09-28 | Ｎｄ２ペプチドおよび神経疾患の治療方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9073976B2 (https=) |
| EP (1) | EP2621945B1 (https=) |
| JP (1) | JP6073230B2 (https=) |
| KR (1) | KR101893473B1 (https=) |
| CN (1) | CN103282379B (https=) |
| AU (1) | AU2011314074B2 (https=) |
| BR (1) | BR112013007557A2 (https=) |
| CA (1) | CA2812948C (https=) |
| DK (1) | DK2621945T3 (https=) |
| IL (1) | IL225464B (https=) |
| MX (1) | MX343366B (https=) |
| RU (1) | RU2607033C2 (https=) |
| SG (1) | SG189104A1 (https=) |
| UA (1) | UA114592C2 (https=) |
| WO (1) | WO2012050921A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106661126B (zh) * | 2014-05-28 | 2021-12-10 | 诺诺公司 | TAT-NR2B9c的氯盐 |
| CN109072242A (zh) * | 2016-02-23 | 2018-12-21 | 科罗拉多州立大学董事会法人团体 | 用于治疗神经损伤的基于肽的方法 |
| KR102253900B1 (ko) * | 2016-04-27 | 2021-05-18 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 흥분성 신경독성 관련 손상 치료용 펩타이드 |
| GB201620611D0 (en) | 2016-12-05 | 2017-01-18 | Univ Of Lancaster | Treatment of neurological diseases |
| CN112679595B (zh) * | 2020-04-10 | 2022-11-01 | 南京市儿童医院 | 脑源肽或融合肽在新生儿缺氧缺血性脑损伤药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999007832A1 (en) * | 1997-08-12 | 1999-02-18 | Bristol-Myers Squibb Company | Kcnq potassium channels and methods of modulating same |
| WO2000056880A1 (en) | 1999-03-19 | 2000-09-28 | Human Genome Sciences, Inc. | 50 human secreted proteins |
| ME00502B (me) * | 2001-01-05 | 2011-10-10 | Amgen Fremont Inc | Antitjela za insulinu sličan receptor faktora i rasta |
| AU2003262642B2 (en) * | 2002-08-14 | 2010-06-17 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors and uses thereof |
| EP1551424B1 (en) * | 2002-09-04 | 2015-07-01 | Arrowhead Research Corporation | Treatment of chronic neuropathic pain by admistration of dsrna |
| US8003609B2 (en) | 2004-03-30 | 2011-08-23 | The Hospital For Sick Children | Method for ameliorating pain by modification of NMDA receptors through inhibition of Src |
| US7425540B2 (en) | 2004-03-30 | 2008-09-16 | The Hospital For Sick Children | Method for modification of NMDA receptors through inhibition of Src |
| AU2006261342B2 (en) * | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
| DK2120987T3 (en) * | 2007-03-02 | 2014-02-24 | Nono Inc | Treatment of stroke and other diseases without inhibiting N-type calcium channels |
-
2011
- 2011-09-28 RU RU2013119830A patent/RU2607033C2/ru active
- 2011-09-28 EP EP11833072.9A patent/EP2621945B1/en active Active
- 2011-09-28 CN CN201180047059.0A patent/CN103282379B/zh not_active Expired - Fee Related
- 2011-09-28 KR KR1020137010823A patent/KR101893473B1/ko not_active Expired - Fee Related
- 2011-09-28 JP JP2013530433A patent/JP6073230B2/ja not_active Expired - Fee Related
- 2011-09-28 DK DK11833072.9T patent/DK2621945T3/en active
- 2011-09-28 CA CA2812948A patent/CA2812948C/en active Active
- 2011-09-28 SG SG2013022397A patent/SG189104A1/en unknown
- 2011-09-28 UA UAA201305474A patent/UA114592C2/uk unknown
- 2011-09-28 MX MX2013003330A patent/MX343366B/es active IP Right Grant
- 2011-09-28 WO PCT/US2011/053764 patent/WO2012050921A2/en not_active Ceased
- 2011-09-28 AU AU2011314074A patent/AU2011314074B2/en not_active Ceased
- 2011-09-28 BR BR112013007557-0A patent/BR112013007557A2/pt not_active Application Discontinuation
-
2013
- 2013-03-15 US US13/842,848 patent/US9073976B2/en active Active
- 2013-03-24 IL IL225464A patent/IL225464B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3371207B1 (en) | Nucleic acids, peptides and methods | |
| ES2643641T3 (es) | Polipéptidos de hormona del crecimiento y métodos de producción y uso de los mismos | |
| JP2014505655A5 (https=) | ||
| Rai | Peptide and protein mimetics by retro and retroinverso analogs | |
| JP2011526886A5 (https=) | ||
| EP2570430A3 (en) | Peptide vaccines with Seq ID No: 78, 41, 44, 46 or 48 for cancers expressing tumor-associated antigens | |
| WO2010111617A4 (en) | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use | |
| JP2010537638A5 (https=) | ||
| JP2014501510A5 (https=) | ||
| JP2013518115A5 (https=) | ||
| ES2694418T3 (es) | Análogos de insulina de cadena sencilla de acción prolongada | |
| JP2010024250A (ja) | 生物学的エフェクターの細胞内送達 | |
| JP2015518479A5 (https=) | ||
| JP2012082206A5 (https=) | ||
| JP2011501652A5 (https=) | ||
| IN2012DN03368A (https=) | ||
| JP2018538356A5 (https=) | ||
| CN117279618A (zh) | 用于靶标分子的选择性耗竭的组合物和方法 | |
| GB2528436A (en) | Treatment of neurological diseases | |
| WO2023235522A1 (en) | Compositions and methods for selective depletion of egfr target molecules | |
| WO2011135222A3 (fr) | Utilisation de peptides comme transporteurs destines a l'internalisation de molecules d'interet dans des cellules cibles | |
| Zhang et al. | Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues | |
| WO2011048503A3 (en) | Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof | |
| MX344229B (es) | Gen insecticida variante axmi115 y metodos para utilizarlo. | |
| JP2011520844A5 (https=) |